Skip to content
The Policy VaultThe Policy Vault

Cabometyx (cabozantinib tablets) — Cigna

Renal cell carcinoma (relapsed or stage IV)

Initial criteria

  • Patient age ≥ 18 years
  • Patient has relapsed or stage IV disease

Approval duration

1 year